Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

Invivo Tcell Imaging

Financiado

Cerrado

Twophoton microscopy analysis of phosphoinositide 3 kinase function during prima...

Twophoton microscopy analysis of phosphoinositide 3 kinase function during primary and secondary T cell activation in vivo The adaptive immune system protects us from nocuous microbes, yet excessive immune reactions can lead to the development of autoimmunity. The initiation of adaptive immune responses takes place in lymphoid organs, including periph... ver más

31/03/2013

UNIVERSITAET BERN

179K€

Presupuesto del proyecto: 179K€

Líder del proyecto

UNIVERSITAET BERN No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2013-03-31 No tenemos la información de la convocatoria

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

UNIVERSITAET BERN

0.00€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

INVIVO TCELL IMAGING Twophoton microscopy analysis of phosphoinositide 3 kinase f... 15K€ Cerrado

2PM T cell Imaging Molecular imaging analysis of the function of the cytoskelet... 45K€ Cerrado

STEP 2 Spatiotemporal regulation of T cell Priming 2M€ Cerrado

KineTic New Reagents for Quantifying the Routing and Kinetics of T c... 2M€ Cerrado

T CELL SIGNALING The spatiotemporal organization of T cell signaling as a reg... 100K€ Cerrado

PI3KS IN DCS The role of the phosphoinositide 3 kinases in the regulation... 168K€ Cerrado

Líder del proyecto

UNIVERSITAET BERN No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 179K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The adaptive immune system protects us from nocuous microbes, yet excessive immune reactions can lead to the development of autoimmunity. The initiation of adaptive immune responses takes place in lymphoid organs, including peripheral lymph nodes (PLN). Inside PLN, T cells become activated through the molecular interactions of the T cell receptor with cognate peptide-MHC (pMHC) molecules and costimulatory molecules on dendritic cells (DC). TCR-mediated signals lead to the activation of the phosphoinositol-3-kinase (PI3K) pathway via the PI3Kδ isoform, which is required for full T cell activation in vitro. However, little is known about the role of the PI3Kδ during primary and secondary in vivo T cell activation. Here, we will use twophoton microscopy (2PM) to observe the interactions of antigen-specific control and PI3Kδ-mutant CD4+ T cells and pMHC-loaded DC deep inside PLN of live, anesthetized mice. Comparing the dynamic interaction parameters obtained in 2PM imaging with the flow cytometric analysis of the activation status of control and PI3Kδ-mutant T cells, we will delineate the precise contribution of the PI3Kδ for primary T cell activation in vivo. We will furthermore perform an analysis of the secondary activation of control and PI3Kδ-mutant effector CD4+ T cells in a mouse model of antigen-induced arthritis. Therefore, we will establish an intravital knee-joint 2PM model to follow the dynamic behavior of control and PI3Kδ-mutant effector T cells with antigen-presenting macrophages in the inflamed tissue. We will combine imaging data with disease scoring, flow cytometry and the use of a PI3Kδ-specific pharmacological inhibitor for a comprehensive analysis of PI3Kδ function at sites of inflammation. In summary, we propose to perform an in-depth analysis of the role of PI3Kδ during adaptive immune response initiation and maintenance. This is also clinically relevant since PI3Kδ inhibitors are in development for immunomodulation.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores